Skip to main content

Table 5 Study weights for pairwise meta-analysis of comparisons in the Parkinson’s data (common effects model)

From: The statistical importance of a study for a network meta-analysis estimate

Comparison

Study

Design

Weight

1:2

2

1:2

0.779

 

3

1:2:4

0.221

3:4

4

3:4

0.612

 

5

3:4

0.388

4:5

6

4:5

0.577

 

7

4:5

0.423

  1. 1 = placebo, 2 = pramipexole, 3 = ropinirole, 4 = bromocriptine, 5 = cabergoline